NASDAQ · Biotechnology

ATAI (ATAI) Stock

$7.25 +0.97% NASDAQ: ATAI Healthcare

Valuation

MetricValue
Price$7.25
Market Cap$2.68B
P/E Ratio-8.44
P/B Ratio6.91
P/S Ratio405.32
EPS (TTM)$0.00
52-Week High$7.25
52-Week Low$2.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-378.00%
ROA-33.34%
ROCE-45.05%
Gross Margin82.02%
Operating Margin-36.58%
Net Margin-190.19%
Debt/Equity0.01
Current Ratio12.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$20.0M$0$0$0$4.0M
Operating Profit$-120.0M$-144.0M$-125.0M$-103.0M$-100.0M
Net Profit$-168.0M$-152.0M$-40.0M$-149.0M$-660.0M
EPS$-1.04$-0.98$-0.25$-0.93$-2.91
Op Margin-590.5%-61987.1%-39958.9%-33341.2%-2439.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$414.0M$305.0M$293.0M$159.0M$311.0M
Total Liabilities$28.0M$40.0M$49.0M$43.0M$89.0M
Cash$362.0M$191.0M$45.0M$18.0M$85.0M
Borrowings$1.0M$15.0M$19.0M$25.0M$2.0M

Latest News

3 Psychedelic Stocks With Potential Clinical Trial Catalysts Simply Wall St. · Jul 10, 2026 AtaiBeckley set to unlock value from positive depression therapy trial results, says Jefferies Proactive · Jul 7, 2026 AtaiBeckley Completes VLS-01 Dosing in Phase IIb Depression Study Zacks · Jul 7, 2026 AtaiBeckley (ATAI) Stock Could Be Overvalued Following Phase 2b Dosing Update Simply Wall St. · Jul 7, 2026 AtaiBeckley (ATAI) Draws Takeover Talk From A Major U.S. Drugmaker Simply Wall St. · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-63.0M$-104.0M$-84.0M$-82.0M$-103.0M
Investing Cash Flow$-82.0M$-88.0M$-54.0M$59.0M$-110.0M
Financing Cash Flow$2.0M$5.0M$-8.0M$0$-22.0M
Net Cash Flow$265.0M$-172.0M$-146.0M$-18.0M$58.0M
Free Cash Flow$-64.0M$-105.0M$-85.0M$-83.0M$-104.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-9.99
FCF Yield-8.29%
Quick Ratio10.02
Interest Coverage-100.00
Return 1Y103.40%
Return 3Y243.54%
Return 5Y-58.69%

Ownership

Insiders Held2.35%
Institutions Held43.88%
Institutions Float Held44.94%
Institutional HolderSharesReport Date
Deep Track Capital, Lp12,000,0002026-03-31
Vanguard Capital Management LLC11,761,3982026-03-31
UBS Group AG7,426,8672026-03-31
Blackrock Inc.6,835,3002026-03-31
Adage Capital Partners GP L.L.C.5,642,7582026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMLX $22.82 -5.66% -8.69 $2.54B 0.00%
DNTH $104.09 +2.44% -17.99 $4.35B 0.00%
ELVN $60.46 +0.32% -19.91 $4.32B 0.00%
IMTX $8.24 -4.52% -4.98 $1.10B 0.00%
INBXInhibrx Biosciences Inc. $81.54 -0.01% -9.72 $1.20B 0.00%

About ATAI

ATAI stock trades at $7.25 with a market capitalization of $2.68B. The stock is valued at a price-to-earnings (P/E) ratio of -8.44, price-to-book of 6.91, price-to-sales of 405.32. Over the past 52 weeks the stock has ranged between $2.00 and $7.25, and currently trades at its 52-week high.

On profitability, ATAI generates a return on equity (ROE) of -378.00%, return on capital employed of -45.05%, an operating margin of -36.58%, a net profit margin of -190.19%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides